ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 149 out of 680

$687K Total Retail Price of All Prescriptions

Rank: 166 out of 680

437 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METFORMIN HCL 416 248 1 8
FUROSEMIDE 367 292 2 6
AMLODIPINE BESYLATE 353 259 3 1
ENALAPRIL MALEATE 342 228 4 65
SIMVASTATIN 340 254 5 3
PRAVASTATIN SODIUM 332 231 6 10
GLIMEPIRIDE 276 231 7 29
WARFARIN SODIUM 262 225 8 20
OMEPRAZOLE 258 194 9 7
NEXIUM 257 182 10 16
TRAMADOL HCL 224 141 11 18
POTASSIUM CHLORIDE 212 147 12 14
METOPROLOL TARTRATE 208 149 13 12
HYDRALAZINE HCL 202 132 14 71
LEVOTHYROXINE SODIUM 190 132 15 2
ISOSORBIDE MONONITRATE ER 175 147 16 59
HYDROCODONE-ACETAMINOPHEN 168 106 S3 17 4
ALLOPURINOL 162 106 18 33
MELOXICAM 159 101 19 24
BUMETANIDE 158 103 20 102
GABAPENTIN 152 121 21 15
NIFEDIPINE ER 143 103 22 75
HYDROCHLOROTHIAZIDE 141 107 23 9
ZOLPIDEM TARTRATE 141 85 23 17
TAMSULOSIN HCL 124 103 25 34
CLOPIDOGREL 123 68 26 26
LISINOPRIL 120 61 27 5
BUSPIRONE HCL 118 88 28 144
NAMENDA 116 103 29 35
CEPHALEXIN 116 78 29 149
METOPROLOL SUCCINATE 114 82 31 13
ATORVASTATIN CALCIUM 112 83 32 11
PLAVIX 100 71 33 39
PROAIR HFA 92 55 34 67
TRIAMTERENE-HCTZ 86 49 35 52
CLONIDINE HCL 86 71 35 36
AZITHROMYCIN 86 57 35 42
CITALOPRAM HBR 84 60 38 22
SYMBICORT 83 52 39 208
CARVEDILOL 81 67 40 23
PREDNISONE 81 37 40 50
CRESTOR 78 67 42 25
PEN NEEDLE 75 34 43 122
LANTUS 75 73 43 49
CARBINOXAMINE MALEATE 73 55 R 45 317
NOVOLOG MIX 70-30 FLEXPEN 73 42 45 289
ADVAIR DISKUS 72 37 47 53
CLOTRIMAZOLE-BETAMETHASONE 68 51 48 138
AMITRIPTYLINE HCL 66 55 R 49 47
GENERLAC 65 65 50 262
FELODIPINE ER 65 65 50 146
LYRICA 62 31 52 77
SPIRIVA 58 43 53 70
BENAZEPRIL HCL 57 48 54 40
PANTOPRAZOLE SODIUM 57 47 54 30
CIPROFLOXACIN HCL 56 37 56 57
PAROXETINE HCL 55 55 57 76
NIASPAN 55 33 57 181
QUETIAPINE FUMARATE 54 28 59 64
BYSTOLIC 54 52 59 79
CARBIDOPA-LEVODOPA 54 53 59 117
METOLAZONE 52 42 62 201
HUMALOG MIX 75-25 52 15 62 268
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.